GlassScriptPhysician profile
Katherine Sterling
NPI 1255919817
$3,338.58
in general payments reported to CMS, 2019-2025
33 companies · $975 in 2025
The $975 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.06 · 2023: $1,503 · 2024: $774 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,252.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $536.82 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $429.93 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $309.48 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $243.30 | 2023-2025 | |
| Axsome Therapeutics, INC. | $227.40 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $191.18 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $181.01 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.61 | 2023-2024 | Xifaxan, Trulance |
| Neurocrine Biosciences, INC. | $121.87 | 2025 | |
| Exact Sciences Corporation | $119.64 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $103.66 | 2023-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $83.95 | 2024-2025 | Voquezna |
| Daiichi Sankyo INC. | $71.55 | 2022-2023 | Injectafer |
| Xeris Pharmaceuticals, INC. | $67.97 | 2023 | Gvoke Hypopen |
| Almatica Pharma LLC | $56.81 | 2023 | Loreev Xr, Sertraline Hcl |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $45.72 | 2023 | Seglentis, Livalo |
| Genzyme Corporation | $43.80 | 2025 | |
| Idorsia Pharmaceuticals US INC | $41.42 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $32.49 | 2023 | Trintellix |
| Tris Pharma INC | $30.65 | 2023-2024 | Dyanavel Xr |
| Edwards Lifesciences Corporation | $26.62 | 2025 | |
| Azurity Pharmaceuticals, INC. | $23.32 | 2023 | Edarbyclor |
| Abbott Laboratories | $20.71 | 2025 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $20.48 | 2023 | |
| Boston Scientific Corporation | $19.69 | 2024 | Watchman Flx |
| Pfizer INC. | $17.07 | 2024 | |
| Astellas Pharma US INC | $16.91 | 2023 | Veozah |
| Antares Pharma, INC. | $16.84 | 2025 | Xyosted |
| Inspire Medical Systems, INC. | $15.25 | 2024 | Inspire |
| Vanda Pharmaceuticals INC. | $15.24 | 2025 | Fanapt |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.24 | 2024 | Jardiance |
| Amgen INC. | $14.21 | 2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $13.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Sterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.